@article{ATM24222,
author = {Vincenzo Di Nunno and Veronica Mollica and Lidia Gatto and Matteo Santoni and Giulia Sorgentoni and Nicola Battelli and Francesco Massari},
title = {Adjuvant therapy in renal cell carcinoma—is pharmacogenomics assessment another element to select our patients?},
journal = {Annals of Translational Medicine},
volume = {7},
number = {Suppl 1},
year = {2019},
keywords = {},
abstract = {Adjuvant therapy in resected renal cell carcinoma (RCC) is a discussed and complex issue due to conflicting results obtained in several clinical trials exploring different agents in this setting (1-4).},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/24222}
}